Cargando…
The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma
SIMPLE SUMMARY: Soft tissue sarcomas (STSs) are rare malignant conditions with more than 70 subtypes that are difficult to treat, especially in advanced or metastatic states. Recently, next-generation sequencing technologies have provided comprehensive information and developed personalized medicine...
Autores principales: | Thiel, Johannes Tobias, Daigeler, Adrien, Kolbenschlag, Jonas, Rachunek, Katarzyna, Hoffmann, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323700/ https://www.ncbi.nlm.nih.gov/pubmed/35884441 http://dx.doi.org/10.3390/cancers14143380 |
Ejemplares similares
-
Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia
por: Rachunek, Katarzyna, et al.
Publicado: (2021) -
Long-term outcomes of patients with soft tissue sarcoma of the chest wall: Analysis of the prognostic significance of microscopic margins
por: Harati, Kamran, et al.
Publicado: (2018) -
Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma
por: Potkrajcic, Vlatko, et al.
Publicado: (2022) -
The Grasping Test Revisited: A Systematic Review of Functional Recovery in Rat Models of Median Nerve Injury
por: Lauer, Henrik, et al.
Publicado: (2022) -
Anti-proliferative activity of epigallocatechin-3-gallate and silibinin on soft tissue sarcoma cells
por: Harati, Kamran, et al.
Publicado: (2017)